Anne is focused on the growth of Evidera’s global real-world evidence database offerings, including the linkage between technology and consultative approaches, and the development and implementation of innovative offerings to better identify, anticipate, and support the needs of biopharmaceutical companies.
Anne’s 25-year career in healthcare has focused on strategy development and deployment with an emphasis on technology-enabled analytics and business intelligence solutions. She has led and fostered international multidisciplinary teams, in both pharmaceutical companies and consultancies, to support the development and validation of strategic plans and commercial decisions for both specific treatment products and companies as a whole. With a keen understanding of client needs, Anne has proven success in developing and deploying innovative and commercially viable solutions to meet the changing demands in the marketplace.
She began her career at SmithKline Beecham (now GlaxoSmithKline) as an international product manager, and then spent several years with the Pharma Strategy Group in London. She then moved to Datamonitor Healthcare where she led a global team to develop compelling pharmaceutical market analysis data. Anne also held vice president roles in portfolio optimization and syndicated analytics for IMS Health, and joins Evidera from GlobalData where she recently held the position of Global Head of Pharma, responsible for the strategic direction and growth of the healthcare business.
Anne is a thought leader in the industry and has given numerous presentations on a variety of healthcare topics at conferences, government organizations, and client groups, including a keynote address to a group of biopharmaceutical clients in Japan titled “Changing Healthcare Dynamics and Implications for the Japanese Market.” She received her master of business administration from the London Business School and her bachelor’s degree in economics from Trinity College Dublin.